Powered by the most advanced Artificial Intelligence and Conversational technologies available, GeneFAX™ changes the way consumers, genetic counselors, and scientists will interact with complex genetic data and how they will engage with genetic testing providers.
Optra Health today announced the introduction of a revolutionary new business solution—GeneFAX™. GeneFAX™ harnesses vast stores of genetic data locked away in corporate and public data silos, combines it with leading edge artificial intelligence and conversational technologies like Amazon Alexa to give genetic testing organizations the ability to offer a ‘round-the-clock’ personalized and engaging service to their consumers, and more effective tools for their genetic counselors and scientists.
Optra Health introduce GeneFAX™ at the HL7 Genomics Conference in Washington D.C., where Mr. Abhi Gholap, Co-founder and Executive Chairman, discussed ‘The Intersection of Artificial Intelligence and Healthcare as it relates to Innovation’.
GeneFAX™ Technology and Amazon Alexa
Consumers have more access to data than ever before which presents potential risks in interpreting complex and often ambiguous information. Genetic Counseling can clear up this ambiguity but may not be readily available when the consumer needs it. GeneFAX, powered by iPhronesis, utilizes Amazon’s Voice Recognition (VR) capabilities for conversation, along with a rich Ontological Library of over 65 million unique life sciences and healthcare concepts and extensive Natural Language Understanding (NLU) and Deep Machine Learning (ML) capabilities provided by the iPhronesis platform to communicate results in a comprehensive and compassionate manner. Consumers can engage in a conversation with GeneFAX™; asking questions and getting detailed answers about their results.
GeneFAX™ is not limited to consumers—genetic testing organizations can deploy GeneFAX™ to their genetic counselors engaged in family screening, allowing them to access and compare reports across an entire family and keep up-to-speed with the latest research – ensuring counseling sessions can be more effective. Additionally, GeneFAX™ can be used by bioinformaticians and scientists involved in data analysis to conversationally interrogate raw data and gather more evidence prior to report generation.
“The convergence of artificial intelligence, conversational technologies like Alexa, and an ever-increasing availability of data is having a transformative effect on how research and clinical results are delivered and communicated,” said Co-founder and CEO Gauri Naik. “The possibilities of using GeneFAX™ and Ai platforms like iPhronesis™ in combination with extensive public and private data sets, will advance research and improve the consumer experience. We look forward to making GeneFAX™ accessible to genetic testing organizations that are interested in providing more value through a personalized, digital approach.”